Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Radiopharmaceuticals Market Outlook

The global radiopharmaceuticals market value was USD 5.38 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe. The market value is anticipated to grow at a CAGR of 7.5% during the forecast period of 2024-2032 to achieve a value of USD 10.31 billion by 2032.

Global Radiopharmaceuticals Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America Market to Continue Dominating the Overall Market Over the Forecast Period

Owing to the presence of prominent pharmaceutical key players and well-funded research facilities, the North America region is estimated to maintain its dominance over the market share for radiopharmaceuticals. Meanwhile, the steady growth of the industry in leading Asia Pacific countries make a worthwhile contribution to the rising regional industry, which is projected to witness the fastest growth in the coming years. The SPECT segment, among the diagnostic radiopharmaceuticals, is extensively utilised in the maintenance of thyroid-related medical issues. Attributing to the commonality of these issues, the thyroid applications of radiopharmaceuticals is likely to witness robust growth during the forecast period. Moreover, under the therapeutic segment, oncology applications are estimated to grow in the coming years owing to a continual rise in the number of cancer cases. Although, due to the higher presence of alternatives in the therapeutic segment, the diagnostic pharmaceuticals are projected to achieve higher growth.

Radiopharmaceuticals: Market Segmentation

A radiopharmaceutical, also known as a medicinal radio compound, is a pharmaceutical drug containing radioisotopes that can be used as a diagnosis medication, as well as a therapeutic agent. Radiopharmaceuticals can be used for both chronic and critical diseases and are widely used in molecular imaging as biomarkers.

Global Radiopharmaceuticals Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By generators type, the market is segmented into:

  • W-188/Re-188 Generators
  • Mo-99/Tc-99m Generators
  • Sr-82/Rb-82 Generators
  • Sr-90/Y-90 Generators
  • Ge-68/Ga-67,68 Generators

Based on application, the industry can be divided into:

  • Diagnostic Radiopharmaceuticals
    • SPECT (Single-Photon Emission Computed Tomography)
    • PET (Positron Emission Tomography)
  • Therapeutic Radiopharmaceuticals
    • Oncology
    • Cardiology and Neurology
  • Theranostics

The end uses for radiopharmaceuticals include:

  • Hospitals
  • Diagnostic Centres

The EMR report looks into the regional markets of radiopharmaceuticals like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Global Radiopharmaceuticals Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Higher Prevalence of Chronic Diseases Likely to Bolster the Market Growth for Radiopharmaceuticals

The radiopharmaceuticals sector is the fastest-growing segment in the pharmaceutical industry. The global market of radiopharmaceuticals is primarily propelled by the worldwide need for timely diagnostics and treatment of fatal diseases. Unhealthy lifestyles of people all over the world has resulted in a higher prevalence of chronic diseases in recent years, and subsequently, the revolutionary utilisation of radiopharmaceuticals in diagnostics is gaining popularity in the healthcare sector.

Moreover, rising acceptance of disease specific therapy, enhanced patient awareness regarding accurate and timely diagnosis, and expanding applications of molecular imaging are some other factors providing a boost to the market growth for radiopharmaceuticals. Meanwhile, various factors including supply volatility and competition from conventional diagnostic procedures, are likely to impede the market growth. Nevertheless, constant growth in the research and development sector, and high capital investment are estimated to counter any such hurdles.

Key Industry Players in the Global Radiopharmaceuticals Market

The report presents a detailed analysis of the following key players in the global radiopharmaceuticals market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Jubilant Pharma Holdings Inc.
  • Clarity Pharmaceutical
  • Cardinal Health
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Applications
  • Volume Assessment
  • Source
  • End User
  • Region
Breakup by Product Type
  • Diagnostic Nuclear Medicine
  • PET Radiopharmaceuticals
  • Therapeutic Nuclear Medicine
  • Brachytherapy Isotopes
  • Beta Emitters
Breakup by Applications
  • SPECT Applications
  • PET applications
  • Therapeutic Applications
Breakup by Volume Assessment
  • Diagnostic Procedures
  • Therapeutic Procedures
Breakup by Source
  • Nuclear Rectors
  • Cyclotrons
Breakup by End User
  • Hospitals
  • Ambulatory Surgical Centres
  • Diagnostic Centres
  • Cancer Research Institutes
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Cardinal Health
  • GE Healthcare
  • Lantheus Medical Imaging
  • Bayer AG
  • Bracco Imaging
  • Nordion
  • NTP Radioisotopes
  • NorthStar Medical Radioisotopes
  • Eckert & Ziegler
  • Braun Melsungen AG
  • Smith Nephew
  • Zimmer Biomet
  • Hanger Inc.
  • Otto Bock Healthcare

Radiopharmaceuticals Market Report Snapshots

Radiopharmaceuticals Market Size

Radiopharmaceuticals Market Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The radiopharmaceuticals Market was valued at USD 5.38 billion in 2023.

The market is expected to grow at a CAGR of 7.5% from 2024 to 2032 to reach a value of USD 10.31 billion by 2032.

The deployment of radiopharmaceuticals in SPECT diagnosis owing to the commonality of thyroid, and the oncology segment of therapeutics is driving the market growth.

The rising prevalence of radiopharmaceuticals to effectively diagnose and treat chronic diseases caused by unhealthy lifestyle is expected to propel the market growth of radiopharmaceuticals.

The major regional markets for radiopharmaceuticals are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

The different types of generators used in the radiopharmaceutical industry are W-188/Re-188 generators, Mo-99/Tc-99m generators, Sr-82/Rb-82 generators, Sr-90/Y-90 generators, and Ge-68/Ga-67,68 generators.

The significant applications of radiopharmaceuticals are diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals, and theranostics.

The major end use sectors of the radiopharmaceutical industry are hospitals, and diagnostic centres.

The major players in the industry are Jubilant Pharma Holdings Inc., Clarity Pharmaceuticals, and Cardinal Health, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124